CMT Research Foundation logo

CMT Research Foundation

Description

CMT Research Foundation has a single focus: provide treatments and cures for CMT.

Investor Profile

CMT Research Foundation has backed more than 5 startups, with 4 new investments in the last 12 months alone. The firm has led 2 rounds, about 40% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Series Unknown rounds (top funding stages).
  • Majority of deals are located in Belgium, United States, The Netherlands.
  • Strong thematic focus on Biotechnology, Therapeutics, Biopharma.
  • Led 2 rounds in the past year.

Stage Focus

  • Series A (60%)
  • Seed (20%)
  • Series Unknown (20%)

Country Focus

  • Belgium (40%)
  • United States (40%)
  • The Netherlands (20%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Biopharma
  • Pharmaceutical
  • Alternative Medicine
  • Genetics
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CMT Research Foundation frequently co-invest with?

AdBio partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Asabys Partners
Europe, Catalonia, Spain, Barcelona
Co-Investments: 2
Gemma Frisius Fund
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 2
VIB
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 2
Lapam Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
V-Bio Ventures
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 2
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 1
CDH Investments
Asia, Kowloon, Hong Kong, Kowloon City
Co-Investments: 1
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 2

What are some of recent deals done by CMT Research Foundation?

XtRNA Bio

Nieuw-amsterdam, Drenthe, The Netherlands

XtRNA Bio is developing a new class of RNA therapeutics targeting genetic diseases caused by translation defects.

Therapeutics
Series UnknownJun 24, 2025
Asha Therapeutics

Tampa, Florida, United States

Asha Therapeutics is a new advance paradigm of drug discovery for re-engineering cellular machinery.

Health CareMedicalTherapeutics
SeedMay 20, 2025
Augustine Therapeutics

Leuven, Vlaams-Brabant, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

BiopharmaBiotechnologyPharmaceutical
Series AMar 24, 2025
Amount Raised: $84,139,626
ReviR Therapeutics

Brisbane, California, United States

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Alternative MedicineBiotechnologyGeneticsTherapeutics
Series AJul 26, 2024
Amount Raised: $30,000,000
Augustine Therapeutics

Leuven, Vlaams-Brabant, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

BiopharmaBiotechnologyPharmaceutical
Series AJun 26, 2024
Amount Raised: $18,206,938